We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTGM
3276
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$72K ﹤0.01%
+111
New +$83.3K
P
3277
DELISTED
Pandora Media Inc
P
$72K ﹤0.01%
14,291
+1,204
+9% +$5.75K
CLNE icon
3278
Clean Energy Fuels
CLNE
$355M
$71K ﹤0.01%
43,050
+5,802
+16% +$9.53K
TA
3279
DELISTED
TravelCenters of America LLC
TA
$71K ﹤0.01%
3,933
-837
-18% -$16.9K
FGB
3280
DELISTED
First Trust Specialty Finance and Financial Opportunities Fund
FGB
$70K ﹤0.01%
11,608
-27,502
-70% -$169K
GSV
3281
DELISTED
Gold Standard Ventures Corp.
GSV
$63K ﹤0.01%
38,717
+493
+1% +$833
CYH icon
3282
Community Health Systems
CYH
$415M
$62K ﹤0.01%
+15,538
New +$78K
BHC icon
3283
CALL
Bausch Health
BHC
$2.37B
$61K ﹤0.01%
33,000
+3,000
+10% +$55.8K
KNDI
3284
Kandi Technologies Group
KNDI
$63.1M
$61K ﹤0.01%
12,600
-9,500
-43% -$55.1K
SREV
3285
DELISTED
ServiceSource International, Inc.
SREV
$61K ﹤0.01%
15,887
-1,233
-7% -$4.42K
NOVN
3286
DELISTED
Novan, Inc. Common Stock
NOVN
$59K ﹤0.01%
+2,000
New +$67K
TTI icon
3287
TETRA Technologies
TTI
$1.28B
$58K ﹤0.01%
15,413
-630
-4% -$2.47K
GNC
3288
DELISTED
GNC Holdings, Inc.
GNC
$58K ﹤0.01%
15,086
+261
+2% +$1.08K
CLDX icon
3289
Celldex Therapeutics
CLDX
$3.37B
$56K ﹤0.01%
1,598
GPRO icon
3290
GoPro
GPRO
$121M
$56K ﹤0.01%
11,673
-34,249
-75% -$196K
MGF
3291
Aberdeen Government Markets Income Fund
MGF
$92.2M
$56K ﹤0.01%
12,024
-7,757
-39% -$36.2K
DFS
3292
CALL
DELISTED
Discover Financial Services
DFS
$54K ﹤0.01%
+24,700
New +$1.91M
VZ icon
3293
CALL
Verizon
VZ
$195B
$54K ﹤0.01%
229,200
-51,900
-18% -$2.61M
XLF icon
3294
CALL
State Street Financial Select Sector SPDR ETF
XLF
$59B
$54K ﹤0.01%
24,400
+3,500
+17% +$101K
APD icon
3295
CALL
Air Products & Chemicals
APD
$68.6B
$53K ﹤0.01%
73,100
+11,600
+19% +$1.91M
NAT icon
3296
Nordic American Tanker
NAT
$1.33B
$53K ﹤0.01%
27,562
-3,367
-11% -$7.71K
PDS
3297
Precision Drilling
PDS
$1.05B
$53K ﹤0.01%
957
+75
+9% +$4.93K
WPRT
3298
PUT
Westport Fuel Systems
WPRT
$35.7M
$53K ﹤0.01%
2,500
-2,300
-48% -$69.5K
IBM icon
3299
CALL
IBM
IBM
$223B
$52K ﹤0.01%
48,221
+1,569
+3% +$237K
GGB icon
3300
Gerdau
GGB
$9.74B
$51K ﹤0.01%
13,860
-1,890
-12% -$6.94K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.